Sıdıka Gerçeker Demircan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sıdıka Gerçeker Demircan has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Bedia Kesimal
Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ophthalmology Department, Ankara, Turkey
2 shared publications - Aysun Sanal Dogan
Ophthalmology Department, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara, Turkey
1 shared publication - Fatma Yülek
Ophthalmology Department, Yıldırım Beyazıt University Ankara Atatürk Training and Research Hospital, Ankara, Turkey
1 shared publication Sücattin İlker Kocamış
Ophthalmology Department Dışkapı Yıldırım Beyazıt Training and Research Hospital Ankara Turkey
1 shared publication
Latest Publications
- Open Access
- 31 July 2026
- Published by Springer Nature in BMC Ophthalmology
- Vol. 26 (1)
Evaluation of plasma glucocorticoid receptor beta levels and intraocular pressure elevation during topical dexamethasone use after photorefractive keratectomy
- 31 July 2026
- Published by Springer Nature in BMC Ophthalmology
- Vol. 26 (1)
Open AccessEvaluation of plasma glucocorticoid receptor beta levels and intraocular pressure elevation during topical dexamethasone use after photorefractive keratectomy
- Open Access
- 2 October 2025
- Published by Springer Nature in BMC Ophthalmology
- Vol. 25 (1) , 1-8
Neovascular glaucoma: comprehensive evaluation of etiology, treatment modalities, and visual prognosis
This study aims to determine the demographic characteristics of patients with neovascular glaucoma (NVG), identify the factors involved in its etiology, and evaluate the effects of various treatment methods on intraocular pressure (IOP). This study included 29 eyes of 24 patients diagnosed with neovascular glaucoma who were treated and followed at a single tertiary eye care center. Patient demographics, medical history, and treatment protocols were recorded, including anti-VEGF injections, panretinal photocoagulation (PRP), and surgical interventions. IOP measurements and best-corrected visual acuity (BCVA) were monitored throughout the follow-up period. Of the patients included in the study, 6 were women and 18 were men, with an average follow-up period of 44.2 ± 34.8 months. The mean age of patients was 67.9 ± 11.4 years, with NVG being caused by diabetic retinopathy (11 eyes), central retinal vein occlusion (6 eyes), ocular ischemic syndrome (6 eyes), and other factors. Pre-treatment IOP was 36.7 ± 7.9 mmHg, which decreased to 18.03 ± 3.19 mmHg post-treatment. Surgical interventions were required in 9 eyes, and significant postoperative IOP reduction was observed. (p˂0.05) Bevacizumab was the most commonly used anti-VEGF agent, with visual acuity outcomes varying among patients, though no statistically significant improvement in BCVA was noted. NVG is a severe condition that requires prompt treatment to prevent permanent vision loss. Anti-VEGF therapy and PRP are essential in controlling neovascularization and reducing IOP, while surgical intervention is often necessary in advanced cases.
- 2 October 2025
- Published by Springer Nature in BMC Ophthalmology
- Vol. 25 (1) , 1-8
Open AccessNeovascular glaucoma: comprehensive evaluation of etiology, treatment modalities, and visual prognosis
This study aims to determine the demographic characteristics of patients with neovascular glaucoma (NVG), identify the factors involved in its etiology, and evaluate the effects of various treatment methods on intraocular pressure (IOP). This study included 29 eyes of 24 patients diagnosed with neovascular glaucoma who were treated and followed at a single tertiary eye care center. Patient demographics, medical history, and treatment protocols were recorded, including anti-VEGF injections, panretinal photocoagulation (PRP), and surgical interventions. IOP measurements and best-corrected visual acuity (BCVA) were monitored throughout the follow-up period. Of the patients included in the study, 6 were women and 18 were men, with an average follow-up period of 44.2 ± 34.8 months. The mean age of patients was 67.9 ± 11.4 years, with NVG being caused by diabetic retinopathy (11 eyes), central retinal vein occlusion (6 eyes), ocular ischemic syndrome (6 eyes), and other factors. Pre-treatment IOP was 36.7 ± 7.9 mmHg, which decreased to 18.03 ± 3.19 mmHg post-treatment. Surgical interventions were required in 9 eyes, and significant postoperative IOP reduction was observed. (p˂0.05) Bevacizumab was the most commonly used anti-VEGF agent, with visual acuity outcomes varying among patients, though no statistically significant improvement in BCVA was noted. NVG is a severe condition that requires prompt treatment to prevent permanent vision loss. Anti-VEGF therapy and PRP are essential in controlling neovascularization and reducing IOP, while surgical intervention is often necessary in advanced cases.
- 24 May 2025
- Published by Wiley in Clinical & Experimental Ophthalmology
- Vol. 53 (7) , 876-877
Optimising the Evaluation of Optic Neuritis YouTube Videos: A Call for Multimedia‐Specific Tools and Audience‐Oriented Approaches—Response
- 24 May 2025
- Published by Wiley in Clinical & Experimental Ophthalmology
- Vol. 53 (7) , 876-877
Optimising the Evaluation of Optic Neuritis YouTube Videos: A Call for Multimedia‐Specific Tools and Audience‐Oriented Approaches—Response
- 23 May 2025
- Published by SAGE Publications in European Journal of Ophthalmology
- Vol. 35 (6) , 2305-2311
Educational quality and reliability of YouTube videos on behçet's uveitis: Higher quality in videos created by physicians
Purpose: This study aimed to evaluate the educational quality and reliability of YouTube videos on Behçet's uveitis, focusing on videos created by physicians and other sources. Methods: A YouTube search using “Behcet's uveitis” was conducted on October 12, 2024, with the first 50 relevant videos included. All video searches were conducted without any user login and after clearing the entire search history, and the first 50 videos were selected based on relevance. Two specialist ophthalmologists independently evaluated the videos using three scoring systems: Journal of the American Medical Association (JAMA), DISCERN, and Health on the Net (HON). Inter-rater reliability was assessed using Cohen's Kappa test, yielding strong agreement for JAMA (κ = 0.86), DISCERN (κ = 0.81), and HON (κ = 0.83). Data on video views, upload time, length, likes/dislikes, authorship, and comments were collected. For statistical analysis, means ± SD were used for JAMA, DISCERN, and HON scores. Linear regression assessed relationships between video features and scores. Independent t-tests evaluated authorship's effect on JAMA, DISCERN, and HON scores. Results: The mean video views were 10,660, with an average length of 1,387 s and 29.1 comments per video. Consensus JAMA, DISCERN, and HON scores were 1.90 ± 0.68, 46.98 ± 1.16, and 3.59 ± 0.65, indicating low quality. Videos by physicians scored higher across all metrics. No other factors significantly affected quality. Conclusion: YouTube videos on Behçet's uveitis generally lack educational quality and reliability. Patients should prioritize videos created by physicians to access accurate and reliable information.
- 23 May 2025
- Published by SAGE Publications in European Journal of Ophthalmology
- Vol. 35 (6) , 2305-2311
Educational quality and reliability of YouTube videos on behçet's uveitis: Higher quality in videos created by physicians
Purpose: This study aimed to evaluate the educational quality and reliability of YouTube videos on Behçet's uveitis, focusing on videos created by physicians and other sources. Methods: A YouTube search using “Behcet's uveitis” was conducted on October 12, 2024, with the first 50 relevant videos included. All video searches were conducted without any user login and after clearing the entire search history, and the first 50 videos were selected based on relevance. Two specialist ophthalmologists independently evaluated the videos using three scoring systems: Journal of the American Medical Association (JAMA), DISCERN, and Health on the Net (HON). Inter-rater reliability was assessed using Cohen's Kappa test, yielding strong agreement for JAMA (κ = 0.86), DISCERN (κ = 0.81), and HON (κ = 0.83). Data on video views, upload time, length, likes/dislikes, authorship, and comments were collected. For statistical analysis, means ± SD were used for JAMA, DISCERN, and HON scores. Linear regression assessed relationships between video features and scores. Independent t-tests evaluated authorship's effect on JAMA, DISCERN, and HON scores. Results: The mean video views were 10,660, with an average length of 1,387 s and 29.1 comments per video. Consensus JAMA, DISCERN, and HON scores were 1.90 ± 0.68, 46.98 ± 1.16, and 3.59 ± 0.65, indicating low quality. Videos by physicians scored higher across all metrics. No other factors significantly affected quality. Conclusion: YouTube videos on Behçet's uveitis generally lack educational quality and reliability. Patients should prioritize videos created by physicians to access accurate and reliable information.